NA
QTTB icon

NewEdge Advisors’s Q32 Bio QTTB Stock Holding History

NewEdge Advisors’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-22
Closed -$395 – 3967
2024
Q2 		$395 Sell
22
-3
-12% -$72 ﹤0.01% 3595
2024
Q1 		$426 Sell
25
-1
-4% -$14 ﹤0.01% 3604
2023
Q4 		$279 Hold
26
– – ﹤0.01% 3580
2023
Q3 		$538 Sell
26
-55
-68% -$1.12K ﹤0.01% 3248
2023
Q2 		$1.29K Buy
81
+55
+212% +$987 ﹤0.01% 3200
2023
Q1 		$474 Sell
26
-10
-28% -$249 ﹤0.01% 3243
2022
Q4 		$247 Buy
+36
New +$956 ﹤0.01% 3274

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

NewEdge Advisors's QTTB Position: Q3 2024 in Review

NewEdge Advisors sold out of Q32 Bio (QTTB) in Q3 2024, closing a stake of 22 shares — an estimated $395 sold.

NewEdge Advisors first reported a position in QTTB in Q4 2022 and held it in 7 quarters. The position peaked at $1.29K in Q2 2023. 73 funds tracked by Wall St. Rank hold QTTB as of Q3 2024.

  • NewEdge Advisors reported no remaining Q32 Bio position as of Q3 2024 after selling out during the quarter.
  • NewEdge Advisors sold 22 Q32 Bio shares in Q3 2024, an estimated $395.
  • NewEdge Advisors first reported a position in Q32 Bio in Q4 2022 and held it in 7 quarters.
  • NewEdge Advisors's Q32 Bio position peaked at $1.29K in Q2 2023.
  • 73 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2024.

Based on NewEdge Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.